c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis

Oncogene

Volumn 22, Issue 36, 2003, Pages 5707-5711

  Kanazawa, Satoshi ^a,b   Soucek, Laura ^a   Evan, Gerard ^a   Okamoto, Takashi ^b   Peterlin, B Matija ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; c Myc; CycT1; P TEFb; Proliferation; Transcription

Indexed keywords

CYCLIN DEPENDENT KINASE 9; MYC PROTEIN; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; RNA POLYMERASE II; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; EUKARYOSIS; GENE TARGETING; GENETIC TRANSCRIPTION; MONKEY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; COS CELLS; GENES, MYC; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC;

ANIMALIA; EUKARYOTA;

EID: 0042337359     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206800     Document Type: Article

References (26)

1. Amati B, Littlewood TD, Evan GI and Land H. (1993). EMBO J., 12, 5083-5087.
2. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N and Peterlin BM. (2001). Mol. Cell, 8, 327-337.
3. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN and Cleveland JL. (2002). Genes Dev. 16, 2530-2543.
4. Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R and Magrath I. (1993). Nat. Genet., 5, 56-61.
5. Chao SH and Price DH. (2001). J. Biol. Chem., 276, 31793-31799.
6. Claassen GF and Hann SR. (1999), Oncogene, 18, 2925-2933.
7. Clark HM, Yano T, Otsuki T, Jaffe ES, Shibata D and Raffeld M. (1994). Cancer Res., 54, 3383-3386.
8. Eberhardy SR and Farnham PJ. (2001). J. Biol. Chem., 276, 48562-48571.
9. Eberhardy SR and Farnham PJ. (2002). J. Biol. Chem.
10. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
11. Grandori C, Cowley SM, James LP and Eisenman RN. (2000). Annu. Rev. Cell. Dev. Biol., 16, 653-699.
12. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB and DePinho RA. (1999). Oncogene, 18, 1219-1226.
13. Juin P, Hueber AO, Littlewood T and Evan G. (1999). Genes Dev., 13, 1367-1381.
14. Kanazawa S, Okamoto T and Peterlin BM. (2000). Immunity, 12, 61-70.
15. Kim YK, Bourgeois CF, Isel C, Churcher MJ and Karn J. (2002). Mol. Cell. Biol., 22, 4622-4637.
16. Lee DK, Duan H and O'Chang C. (2001). J. Biol. Chem., 276, 9978-9984.
17. Lis JT, Mason P, Peng J, Price DH and Werner J. (2000). Genes Dev., 14, 792-803.
18. Nasi S, Ciarapica R, Jucker R, Rosati J and Soucek L. (2001). FEBS Lett., 490, 153-162.
19. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F and Eilers M. (1997). EMBO J., 16, 5672-5686.
20. Price DH. (2000). Mol. Cell. Biol., 20, 2629-2634.
21. Ramanathan Y, Rajpara SM, Reza SM, Lees E, Shuman S, Mathews MB and Pe'ery T. (2001). J. Biol. Chem., 276, 10913-10920.
22. Sakamuro D and Prendergast GC. (1999). Oncogene, 18, 2942-2954.
23. Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, De Luca A, Guanti G, Puri PL and Giordano A. (2002). Oncogene, 21, 4137-4148.
24. Soucek L, Helmer-Citterich M, Sacco A, Jucker R, Cesareni G and Nasi S. (1998). Oncogene, 17, 2463-2472.
25. Wei P, Garber ME, Fang SM, Fischer WH and Jones KA. (1998). Cell, 92, 451-462.
26. Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH and Brady JN. (2000). Mol. Cell. Biol., 20, 5077-5086.